Event 
Partner 
Milestone 
2018-03-31
Jul 02-03 ACT Genomics unlocks the value of comprehensive genomic profiling in World Medicine 2018
Unlock the value of comprehensive genomic profiling: lessons and case studies in cancer management
Place:
Thailand
2018-03-31
May 05-06 Novel treatment strategies in precision cancer medicine in TJCC
ACT Genomics invites the Deputy Director of Tokyo Medical and Dental University Cancer Center, Dr. Sadakatsu Ikeda as guest speaker and the Director of National Taiwan Hospital Graduate Institute of Oncology, Dr. James Chih-Hsin Yang as moderator, to shar
Place:
Taipei
2018-03-31
Apr 04&06 ACT Genomics is invited to share promises and challenges of NGS in Singapore
Dr. Maarja-Liisa Nairismagi will be sharing on the topic, Can Next Generation Sequencing Fulfill its Promises in Cancer Management in the Era of Precision Medicine and promises and challenges of Next Generation Sequencing in cancer management.
Place:
Singapore
2018-03-31
Mar 23 An exemplary high-tech biomedical enterprise in Southeast Asia
ACT Genomics successfully positions itself as an exemplary high-tech enterprise for Taiwan’s biomedical companies in their south bound strategy to clinch the emerging market
Place:
Singapore
2018-03-31
Mar 20 Finding a way to avoid genetic discrimination
Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics joined oncologists to explore detection of germline mutations with NGS, share cases of early cancer treatment, and discuss how to assist patients with hereditary genetic mutations to avoid genetic
Place:
Hong Kong
2018-03-31
Mar 19 The rising star in Asia’s genomic profiling platform
Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics introduced how personal genomic information can be transformed into guidance for cancer treatment selection through their know-how, which attracted investors’ attention.
Place:
Japan
2018-03-31
Mar 16 ACT Genomics shared NGS experiences in cancer management
. Dr. Maarja-Liisa Nairismagi shared on promises and challenges of Next Generation Sequencing in cancer management in Singapore
Place:
Singapore
2018-03-31
Mar 09 NGS market insight for Economist Intelligence Unit
Dr. Allen Lai, Senior Vice President, has been interviewed by EIU on 9th March to provide his critical in-field observation of the trend and the adoption challenges of NGS in the years to come in Southeast Asia and beyond.
Place:
Singapore
2018-03-31
Mar 09 Creating biomedical ecosystem to facilitate medical advances in Southeast Asia
Dr. Lai illustrate the importance of creating an enabling biomedical ecosystem to facilitate development and access to innovative medical advances in several countries in Asia.
Place:
Singapore
2018-03-31
ACT Genomics shared knowledge on genetics of hematological malignancies
Dr. Maarja-Liisa Nairismagi shared knowledge on the genetics of hematological malignancies and the usage of tumor mutational burden (TMB) as a biomarker.
Place:
Singapore
